4
Total investments
2
Early stage
1
Mid stage
1
Late stage
6y
Years active
Portfolio
4 investments Β· sorted by recency
All investments
Early stage
Mid stage
Late stage
Early Stage Investor
Feb 2024
The worlds first AI Customer Acquisition Platform. We work with the top-tier industry traffic supply partners, the leading Conversational AI Platforms, and lead/call buyers of all sizes across all the biggest B2C Lead Gen verticals and categories.
The potential scale of the B2C AI Customer Acquisition market is in the trillion-dollar range annually. However, this arena remains surprisingly under-discussed among investors. Valid reasons exist, from gradual integration of AI so far to perceived risks, but the sheer size of the prize warrants a closer look by forward-thinking ventures.
Symphony42 offers a compelling model to tap into this potential transformation of marketing and consumer interactions. By using conversational AI to qualify leads through consumer-initiated engagement, we address the performance pitfalls of conventional interruptive tactics. The Symphony42 founding team brings together specialized expertise in both AI and direct sales to make this vision a reality.
Key differentiators include developing specialized platforms purpose-built for AI Customer Acquisition, strategically partnering to remain capital efficient with foundational AI, and accumulating invaluable proprietary training data over time. Our phased product roadmap enables rapid validation while expanding platform capabilities. AI will enhance efficiency.
The path forward lies in achieving win-win value -- increased sales and revenue from Symphony42 customers coupled with positive personalized experiences for consumers.
B2C AI Customer Acquisition holds immense untapped potential, especially for Symphony42.
The future of marketing and consumer interaction is now :-)
Board Member
Jan 2024
The VAB community was created to connect top talented senior professionals from around the globe and help them engage with CEOs/Chairmen of different industries and sectors to address the latters business challenges. Our community value proposition is to provide a personalised and exclusive boutique platform for our advisors and clients. At VAB, our programmes focus on learning, networking, and connecting by supporting members as they advance along their board journeys (helping them use their networks to find new roles) and introducing them to partners who can help them further develop their board leadership skills.
Once a member, we will share your background with our clients for Board/Advisor opportunities when they arise and match your profile.
For more information you can contact david@virtualadvisoryboard.co.uk
Early Stage Investor
May 2022
Our mission is simple and clear: we help organizations win more business by helping them craft better proposals in a fraction of the time.
Our solution combines the power of AI, your existing knowledge library and specialist features designed by bid-writers, for bid-writers, to ensure you have the competitive edge. An AutogenAI Language Engine will make your bid-writing team up to 8X more efficient, allow them to get to first draft in minutes rather than days and boost your win rates by up to 30%.
Our team is made up of dedicated specialists in procurement, bid writing, and machine learning, each one contributing to the exceptional solutions we deliver.
We believe that every organization is unique with its own specific needs and specifications. This is why we offer tailored solutions, with customizable options ranging from personalized language style to bespoke prompts.
We are proud to be one of the fastest growing generative AI companies out there. Our method works, and our results speak for themselves.
At AutogenAI, we understand that winning is the most crucial goal. It is through this lens that we deliver true value.
Investor
Jun 2020
Join the revolution! Weβre changing the way the world treats inflammation and the way the pharma industry treats humanity. Invest today β https://wefunder.com/senjam
Sen-Jams Global scientists have developed a multi-indication patent and FDA-pending product for the prevention of pain and flu-like symptoms for indications not currently being addressed by the FDA OTC Drug Monograph.
Its time for a stronger, more resilient world, free of side-effects and filled with living remarkably
Experience Β· 5 entries
All (5)
Investments (4)
Board (1)
2024
Early Stage Investor
Feb 2024
The worlds first AI Customer Acquisition Platform. We work with the top-tier industry traffic supply partners, the leading Conversational AI Platforms, and lead/call buyers of all sizes across all the biggest B2C Lead Gen verticals and categories.
The potential scale of the B2C AI Customer Acquisition market is in the trillion-dollar range annually. However, this arena remains surprisingly under-discussed among investors. Valid reasons exist, from gradual integration of AI so far to perceived risks, but the sheer size of the prize warrants a closer look by forward-thinking ventures.
Symphony42 offers a compelling model to tap into this potential transformation of marketing and consumer interactions. By using conversational AI to qualify leads through consumer-initiated engagement, we address the performance pitfalls of conventional interruptive tactics. The Symphony42 founding team brings together specialized expertise in both AI and direct sales to make this vision a reality.
Key differentiators include developing specialized platforms purpose-built for AI Customer Acquisition, strategically partnering to remain capital efficient with foundational AI, and accumulating invaluable proprietary training data over time. Our phased product roadmap enables rapid validation while expanding platform capabilities. AI will enhance efficiency.
The path forward lies in achieving win-win value -- increased sales and revenue from Symphony42 customers coupled with positive personalized experiences for consumers.
B2C AI Customer Acquisition holds immense untapped potential, especially for Symphony42.
The future of marketing and consumer interaction is now :-)
Board Member
Jan 2024
The VAB community was created to connect top talented senior professionals from around the globe and help them engage with CEOs/Chairmen of different industries and sectors to address the latters business challenges. Our community value proposition is to provide a personalised and exclusive boutique platform for our advisors and clients. At VAB, our programmes focus on learning, networking, and connecting by supporting members as they advance along their board journeys (helping them use their networks to find new roles) and introducing them to partners who can help them further develop their board leadership skills.
Once a member, we will share your background with our clients for Board/Advisor opportunities when they arise and match your profile.
For more information you can contact david@virtualadvisoryboard.co.uk
2022
Early Stage Investor
May 2022
Our mission is simple and clear: we help organizations win more business by helping them craft better proposals in a fraction of the time.
Our solution combines the power of AI, your existing knowledge library and specialist features designed by bid-writers, for bid-writers, to ensure you have the competitive edge. An AutogenAI Language Engine will make your bid-writing team up to 8X more efficient, allow them to get to first draft in minutes rather than days and boost your win rates by up to 30%.
Our team is made up of dedicated specialists in procurement, bid writing, and machine learning, each one contributing to the exceptional solutions we deliver.
We believe that every organization is unique with its own specific needs and specifications. This is why we offer tailored solutions, with customizable options ranging from personalized language style to bespoke prompts.
We are proud to be one of the fastest growing generative AI companies out there. Our method works, and our results speak for themselves.
At AutogenAI, we understand that winning is the most crucial goal. It is through this lens that we deliver true value.
2020
Investor
Jun 2020
Join the revolution! Weβre changing the way the world treats inflammation and the way the pharma industry treats humanity. Invest today β https://wefunder.com/senjam
Sen-Jams Global scientists have developed a multi-indication patent and FDA-pending product for the prevention of pain and flu-like symptoms for indications not currently being addressed by the FDA OTC Drug Monograph.
Its time for a stronger, more resilient world, free of side-effects and filled with living remarkably
1999
Managing Director Tanzania
1999
When you ship with DHL Express, youre shipping with specialists in international logistics and courier delivery. We offer a wide range of express and parcel services, along with tracking and support solutions to fit your needs - so find out how DHL Express can deliver for you!
Investment activity
2020β2024 Β· 4 investments
Recent (last 2 years)Earlier
